Putting the brakes on aging
Aging is a leading risk factor for a number of debilitating conditions, including heart disease, cancer and Alzheimer’s disease, to name a few. This makes the need for anti-aging therapies all the more urgent. Now, Salk Institute researchers have developed a new gene therapy to help decelerate the aging process.
The findings, published on February 18, 2018 in the journal Nature Medicine, highlight a novel CRISPR/Cas9 genome-editing therapy that can suppress the accelerated aging observed in mice with Hutchinson-Gilford progeria syndrome, a rare genetic disorder that also afflicts humans. This treatment provides important insight into the molecular pathways involved in accelerated aging, as well as how to reduce toxic proteins via gene therapy.
“Aging is a complex process in which cells start to lose their functionality, so it is critical for us to find effective ways to study the molecular drivers of aging,” says Juan Carlos Izpisua Belmonte, a professor in Salk’s Gene Expression Laboratory and senior author of the paper. “Progeria is an ideal aging model because it allows us to devise an intervention, refine it and test it again quickly.”
With an early onset and fast progression, progeria is one of the most severe forms of a group of degenerative disorders caused by a mutation in the LMNA gene. Both mice and humans with progeria show many signs of aging, including DNA damage, cardiac dysfunction and dramatically shortened life span. The LMNA gene normally produces two similar proteins inside a cell: lamin A and lamin C. Progeria shifts the production of lamin A to progerin. Progerin is a shortened, toxic form of lamin A that accumulates with age and is exacerbated in those with progeria.
“Our goal was to diminish the toxicity from the mutation of the LMNA gene that leads to accumulation of progerin inside the cell,” says co-first author Hsin-Kai Liao, a staff researcher in the Izpisua Belmonte lab. “We reasoned that progeria could be treated by CRISPR/Cas9-targeted disruption of both lamin A and progerin.”
The researchers utilized the CRISPR/Cas9 system to deliver the gene therapy into the cells of the progeria mouse model expressing Cas9. An adeno-associated virus (AAV) was injected containing two synthetic guide RNAs and a reporter gene. The guide RNA ushers the Cas9 protein to a specific location on the DNA where it can make a cut to render lamin A and progerin nonfunctional, without disrupting lamin C. The reporter helps researchers track the tissues that were infected with the AAV.
Two months after the delivery of the therapy, the mice were stronger and more active, with improved cardiovascular health. They showed decreased degeneration of a major arterial blood vessel and delayed onset of bradycardia (an abnormally slow heart rate)—two issues commonly observed in progeria and old age. Overall, the treated progeria mice had activity levels similar to normal mice, and their life span increased by roughly 25 percent.
“Once we improve the efficiency of our viruses to infect a wide range of tissues, we are confident that we will be able to increase life span further,” says Pradeep Reddy, a postdoctoral fellow in the Izpisua Belmonte lab and an author of the paper.
Taken together, the results suggest that targeting lamin A and progerin using a CRISPR/Cas9 system can dramatically improve the physiological health and life span of progeria mice. These results provide a significant new understanding of how scientists may eventually be able to target molecular drivers of aging in humans.
Future efforts will focus on making the therapy more effective and will refine it for human use. Currently, there is no cure for progeria, so the symptoms are managed and complications are treated as they arise.
“This is the first time a gene editing therapy has been applied to treat progeria syndrome,” says Izpisua Belmonte, holder of the Roger Guillemin Chair. “It will need some refinements, but it has far fewer negative effects compared to other options available. This is an exciting advancement for the treatment of progeria.”
Learn more: Putting the brakes on aging
The Latest on: Anti-aging therapies
via Google News
The Latest on: Anti-aging therapies
- Breast Reconstruction and Augmentation Market Size and Share Is Estimated to Grow at a 3.8& CAGR By 2023on January 25, 2021 at 9:36 am
Breast Reconstruction and Augmentation Market Insights. Market Research Future has provided a comprehensive valuation of the breast augmentation implants market recently including ...
- HealthGAINS Aventura optimizes vitality and changes liveson January 25, 2021 at 5:59 am
The mission of HealthGAINS has always been to use cutting-edge medicine and technology to help patients reach their ultimate goals, becoming the best version of themselves, and living their ...
- Anti Aging Market In-deep Analysis And Experts Review Report 2020-2025on January 21, 2021 at 8:01 pm
The global anti aging market is expected to exceed more than US$ 271.0 Billion by 2024; Growing at a CAGR of about 8% in ...
- These Under-$5 Microneedling Patches May Reduce Wrinkles in Just 2 Weekson January 21, 2021 at 10:40 am
These innovative patches from Peace Out help penetrate the skin to help reduce the appearance of wrinkles — find out more ...
- Breakthrough study finds age-related cognitive decline may be reversibleon January 20, 2021 at 4:51 pm
A breakthrough study from a team of neurologists at Stanford University claims to have discovered one way immune cells become dysfunctional as we age, leading to the inflammatory hyperdrive that plays ...
- New Data Shows This Anti-Aging In-Office Treatment Is Majorly Trendingon January 20, 2021 at 2:32 pm
In 2019, filling fine lines with injectable treatments was a top procedure, along with body-sculpting and laser treatments.
- Anti-Aging Market 2020 Driving Factors, Industry Growth, Key Vendors and Forecasts to 2027on January 20, 2021 at 6:32 am
Selbyville, Delaware, As per the report titled 'GLOBAL ANTI-AGING MARKET 2019-2027', available with Market Study Report LLC, global anti-aging market is estimated to record a yearly growth rate of ...
- This Anti-Aging Eye Cream Is So Good, Shoppers Call It a ‘Magic Wrinkle Eraser’on January 15, 2021 at 1:49 pm
And one under-$20 anti-aging eye cream has done just that, turning skeptics into believers with its targeted treatment for improving the appearance of fine lines and wrinkles. The $17 Neutrogena Rapid ...
- Sacramento Area Patients Flock to Medspa Offering the Latest in Skin Tightening and Wrinkle Reduction Therapieson January 13, 2021 at 12:00 pm
As a top skin rejuvenation specialist in the greater Sacramento area, Dr. Luis Lee offers patients only the best of the best skin ...
- The Anti-Aging Device Jessica Simpson Uses on Her ‘Scalp, Stomach and Boobs’on January 13, 2021 at 9:17 am
If Jessica Simpson does it, we must too! Here, she spills on her number-one anti-aging tip and how she got rid of her eczema.
via Bing News